Semaglutide (FITC-labeled Semaglutide) is a long-acting analog of human glucagon-like peptide-1, functioning as an agonist of the GLP-1 receptor. It shows potential for research related to type 2 diabetes.
Formula:
C209H304N46O63S
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted